Cardinal Health, a global distributor of pharmaceuticals and medical products, has announced that it will contribute its Outcomes business to Transaction Data Systems (TDS) in exchange for a minority stake in the combined entity. TDS, a portfolio company of BlackRock Long Term Private Capital and GTCR, specializes in pharmacy management systems and patient communication-pharmacy enablement applications. The merger will create an integrated offering of pharmacy workflow software, patient engagement solutions, and clinical care services to benefit the patient, pharmacy, payer, and pharmaceutical company ecosystem.
The combined organization aims to expand TDS’s existing clinical pharmacy solutions by incorporating Outcomes’ digital capabilities for patient engagement, virtual verification, order grouping, pill counting, and financial insights. This partnership will provide opportunities for pharmacists to participate in sponsored clinical interventions while enhancing access for payors and pharmaceutical companies to drive improved care and outcomes for patients.
The transaction is expected to be completed in the third quarter of 2023, pending customary closing conditions and regulatory approvals. Cardinal Health’s pharmaceutical segment CEO, Debbie Weitzman, will join the TDS board of directors.
By leveraging the strengths of both companies, Cardinal Health and TDS seek to elevate the level of personal care offered by pharmacies, improve operational efficiency, and achieve better clinical and financial results. This strategic collaboration reflects the commitment to enhancing care delivery and maximizing clinical reimbursement in the pharmacy sector, ultimately benefiting patients and optimizing the pharmacy industry as a whole.
Readd More News: Click Here
